Jothydev spoke to around 40 doctors from various pecialities on Newer Insulins and delivery devices.Dr.Aravind, r.Ambady, Dr.Oommen(handing momento to Jothydev) spoke. The seminar also dicussed the disappearance of Exubera from global market before getting launched in India.Dr.Jothydev Kesavadev commented that the fate of the first powder insulin inhaler, Exubera is mainly because of the fact that dose increments are not possible by one units each whereas Aerex inhaler with liquid insulin from Novo will be a big hit in the market in future. Exenatide despite the long waiting has spread concerns among the scientific community , with recent FDA warning on acute pancreatitis.